- Home
- ITRG vs FULC Comparison
ITRG vs FULC Comparison
Compare ITRG & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | FULC |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.5M | 468.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | ITRG | FULC |
|---|---|---|
| Price | $4.32 | $12.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | $4.00 | ★ $16.38 |
| AVG Volume (30 Days) | 1.7M | ★ 2.6M |
| Earning Date | 11-12-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $219,125,000.00 | N/A |
| Revenue This Year | $1,016.77 | N/A |
| Revenue Next Year | $7.81 | N/A |
| P/E Ratio | $54.64 | ★ N/A |
| Revenue Growth | N/A | ★ 2752.05 |
| 52 Week Low | $0.79 | $2.32 |
| 52 Week High | $4.36 | $15.74 |
Technical Indicators
Market Signals| Indicator | ITRG | FULC |
|---|---|---|
| Relative Strength Index (RSI) | 77.87 | 61.65 |
| Support Level | $3.53 | $12.56 |
| Resistance Level | $3.99 | $15.32 |
| Average True Range (ATR) | 0.20 | 1.27 |
| MACD | 0.08 | 0.30 |
| Stochastic Oscillator | 99.34 | 60.90 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.